Anna Ravnefjord

 

Anna Ravnefjord is a senior professional in global regulatory affairs, with deep and long-ranging experience in clinical trials at Phase 1, 2a and 2b; IND applications and interactions with EU and US regulatory authorities. She is highly skilled in marketing authorisation applications and license maintenance activities for both development products and mature brands. Anna has held senior regulatory and research roles at AstraZeneca. She is a published scientist and holds a degree from Gothenburg University.

 

To the Arex team page